Melanoma of the female urethra

Česká verzia

Authors: Rodrigo Gouveia ¹; David Cibula ²; Viktor Soukup ¹; Tomáš Hanuš ¹
Authors place of work: Urologická klinika, Všeobecná fakultní nemocnice a 1. LF UK v Praze ¹; Gynekologicko‑Porodnická klinika, Všeobecná fakultní nemocnice a 1. LF UK v Praze ²
Published in the journal: Ces Urol 2019; 23(2): 149-154
Category: Case report

Summary

Melanoma of the urethra, or melanomas originating from the gynecological tract, are extremely rare and aggressive malignant tumors, with high metastatic potential and a poor prognosis, affecting almost exclusively elder female patients. The aim of this case report is to present the case of a patient with urethral and bladder melanoma metastasis from a previously treated primary melanoma of the vulva. Radical cystourethrectomy and Bricker-Nesbit ureteroileostomy and bilateral extended pelvic lymphadenectomy were performed. Histology report confirmed melanoma invading the urethra and bladder, all removed lymphatic nodes were negative. On the 6-month follow‑up PET‑CT there was no evidence of residual disease. We concluded that in the presence of such a suspicious urethral lesion, prompt diagnosis to differentiate from other benign lesions and early radical management with careful post‑operative follow‑up schedules should be the standard treatment.

Keywords:

Malignant melanoma of the urethra – metastatic melanoma of the vulva – radical cystourethrectomy

Zdroje

1. Safadi A, Schwalb S, Ben‑Shachar I, Katz R. Primary malignant urethral melanoma resembling a urethral caruncle. Urology Case Reports 2017. https://doi.org/10.1016/j.eucr.2017. 08. 004.

2. Akbas A, Akman T, Erdem MR, et al. Female urethral malignant melanoma with vesical invasion: a case report. Kaohsiung J Med Sci. 2010; 26: 96–98.

3. Bartoš V, Mikuláš J, Pokorný D, Lamoš P. Malígny melanóm uretry u staršej pacientky – popis prípadu. Klin urol 2018; 14(3): 124–126.

4. Bhutani N, Kajal P, Pawar D. Primary malignant melanoma of the female urethra: Report of a rare neoplasm of the urinary tract. International Journal of Surgery Case Reports 2017; 41: 319–322. doi: 10.1016/j. ijscr.2017. 11. 001.

5. Amiraian D, Cernigliaro J, Zhai QJ, Petrou S. Primary malignant melanoma of the female urethra: A radiologic‑pathologic correlation. Cancer Treatment Communications. Cancer Treatment Communications 2015; 3: 13–16. https://doi.org/10.1016/j.ctrc.2015. 01. 003.

6. Katz EE, Suzue K, Will, MA, et al. Primary malignant melanoma of the urethra. Urology. https://doi. org/10.1016/j.urology 2005; 65(2): 389. 2004. 09. 002

7. Papeš D, Altarac S, Arslani N, et al. Melanoma of the glans penis and urethra. Urology, 2014; 83(1): 6–11.

8. Šamudovský R, Všetička J. Maligní melanom uretry. Urol. praxi 2015; 16(4): 165–168.

9. Gadducci A, Carinelli S, Guerrieri ME, Aletti GD. Melanoma of the lower genital tract: Prognostic factors and treatment modalities. Gynecologic Oncology 2018; 150(1): 180–189. https://doi.org/10.1016/j. ygyno.2018. 04. 562

10. Seetharamu N, Patrick AO, Anna C, Pavlick AC. Mucosal melanomas: a case‑based review of the literature. The Oncologist 2010; 15: 772–781.

11. Moxley KM, Fader AN, Rose PG, et al. Malignant melanoma of the vulva: An extension of cutaneous melanoma? Gynecologic Oncology 2017; (64)3. https://doi.org/10.1016/j.ygyno.2011. 04. 007.

12. Skovsted S, Nielsen K, Blaakær J. Melanomas of the vulva and vagina. Danish Medical Journal 2017. https://doi.org/10.1109/CBMS.2010.6042634.

13. Lež C, Altarac S, Fureš R, Čupic H. Primary malignant melanoma of the female urethra. Gynaecol Perinatol 2010; 19(2): 94–96.

14. Kim CJ, Pak K, Hamaguchi A, et al. Primary malignant melanoma of the female urethra. Cancer 1993; 71(2): 448–451.

15. Geisler JP, Look KY, Moore DA, Sutton GP. Pelvic exsenteration for malignant melanomas of the vagina or urethra with over 3 mm of invasion. Gynecol Oncol 1995; 59: 338–341.

16. Lukač J, Šesto D, Davkovic N, et al. Interferon u liječenju u solidnih tumora. Liječ Vjesn 1994; 116: 303–307.

17. Creagan ET, Ahmann DL, Green SJ, et al. Phase II study of low‑dose recombinant leukocyte A interferon in disseminated malignant melanoma. J Clin Oncol 1984; 2: 1002–1005.

18. Legha SS. Interferons in the treatment of malignant melanoma. A review of recent trials. Cancer 1986; 57 (Suppl): 1675–1677.